Consequence of RNA oxidation
RNA氧化的后果
基本信息
- 批准号:7244082
- 负责人:
- 金额:$ 15.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-01 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAreaAutopsyBiologicalBiologyBrainCell DeathCell physiologyCellsCessation of lifeComplexDNA Microarray ChipDNA Microarray formatDataDeteriorationDiseaseEtiologyEventFree RadicalsFutureIn VitroInvestigationLaboratory StudyLeadLipidsMessenger RNAMethodsMicroinjectionsModificationMorphologic artifactsNerve DegenerationNeurodegenerative DisordersNeurologicNeuronsNucleic AcidsNucleosidesPathogenesisPatientsPlayPoly AProceduresProcessProteinsRNAResearch PersonnelRoleSolidSystemTissuesTranslatingcDNA Arraysinsightnoveloxidationprotein expressionprotein function
项目摘要
DESCRIPTION (provided by applicant): Cytoplasmic RNA oxidation is a prominent feature of vulnerable neurons in the brains of Alzheimer's disease (AD) patients. However, the role of RNA oxidation in the pathogenesis of AD is still unknown. We have recently developed a novel procedure to isolate and characterize oxidized RNA. We found that up to 50% of poly(A)+ mRNAs are oxidized in AD brains. Identification of oxidized mRNA species revealed that some mRNAs are more susceptible to oxidative damage; thus, RNA oxidation is not random but highly selective. Importantly, many identified oxidized mRNA species have been implicated in the pathogenesis of AD. Investigation of the consequence of oxidatively damaged mRNAs revealed that oxidized mRNA could not be translated properly leading to reduced protein expression and consequently, loss of normal protein function. Significantly, microinjection of oxidized mRNAs into neuronal cells leads to cell death, suggesting that increased RNA oxidation could lead to cell death. Furthermore, several lines of evidence suggest that RNA oxidation is an early event preceding cell death, not an artifact of dying cells. Taken these studies together, RNA oxidation itself is directly associated with neuronal deterioration instead of harmless epiphenomenona during the process of neurodegeneration. This is an important, yet understudied area. Further detailed investigation is needed. We hypothesize that oxidative damage to mRNA could result in protein malfunction, which could contribute to neuronal death in AD. In Aim 1, we propose to further identify oxidized mRNA species by cDNA microarray, to quantify the oxidation level for each oxidized mRNAs, and to investigate the proteins corresponding to the identified oxidized mRNA species in AD. This study will identify those highly oxidized mRNA species and determine whether proteins corresponding to those highly oxidized mRNA species are defective. In Aim 2, we propose to investigate the biological consequence of RNA oxidation. These studies will elucidate whether RNA oxidation plays a role in the pathogenesis of AD.
描述(申请人提供):细胞质RNA氧化是阿尔茨海默病(AD)患者大脑中脆弱神经元的一个显著特征。然而,RNA氧化在AD发病机制中的作用尚不清楚。我们最近开发了一种新的方法来分离和鉴定氧化的RNA。我们发现,在阿尔茨海默病的大脑中,多达50%的聚(A)+mRNAs被氧化。对氧化的mRNA物种的鉴定表明,一些mRNAs更容易受到氧化损伤;因此,RNA的氧化不是随机的,而是具有高度选择性的。重要的是,许多已发现的氧化型信使核糖核酸与AD的发病机制有关。对氧化损伤mRNAs后果的研究表明,氧化后的mRNAs不能正确翻译,导致蛋白质表达减少,从而丧失正常的蛋白质功能。值得注意的是,将氧化的mRNAs微量注射到神经细胞中会导致细胞死亡,这表明RNA氧化增加可能导致细胞死亡。此外,一些证据表明,RNA氧化是细胞死亡之前的早期事件,而不是死亡细胞的人工制品。综上所述,RNA氧化本身与神经元退化直接相关,而不是与神经变性过程中无害的表观现象有关。这是一个重要但尚未得到充分研究的领域。还需要进一步的详细调查。我们假设,氧化损伤的信使核糖核酸可能导致蛋白质功能障碍,这可能导致AD的神经元死亡。在目标1中,我们建议通过基因芯片进一步鉴定氧化的mRNA物种,定量每个氧化的mRNAs的氧化水平,并研究在AD中与所鉴定的氧化的mRNA物种相对应的蛋白质。这项研究将鉴定那些高度氧化的mRNA物种,并确定与这些高度氧化的mRNA物种相对应的蛋白质是否存在缺陷。在目标2中,我们建议研究RNA氧化的生物学后果。这些研究将阐明RNA氧化是否在AD的发病机制中起作用。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Oxidative damage to RNA: mechanisms, consequences, and diseases.
- DOI:10.1007/s00018-010-0277-y
- 发表时间:2010-06
- 期刊:
- 影响因子:8
- 作者:Kong, Qiongman;Lin, Chien-liang Glenn
- 通讯作者:Lin, Chien-liang Glenn
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHIEN-LIANG GLENN LIN其他文献
CHIEN-LIANG GLENN LIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHIEN-LIANG GLENN LIN', 18)}}的其他基金
Development of a small-molecule that enhances tripartite synapses for Alzheimers disease
开发一种增强阿尔茨海默病三联突触的小分子
- 批准号:
10474460 - 财政年份:2020
- 资助金额:
$ 15.42万 - 项目类别:
Target identification of small molecule LDN/OSU-215111
小分子LDN/OSU-215111的靶点鉴定
- 批准号:
9885609 - 财政年份:2020
- 资助金额:
$ 15.42万 - 项目类别:
Development of a small-molecule that enhances tripartite synapses for Alzheimers disease
开发一种增强阿尔茨海默病三联突触的小分子
- 批准号:
10045319 - 财政年份:2020
- 资助金额:
$ 15.42万 - 项目类别:
Development of a small-molecule that enhances tripartite synapses for Alzheimers disease
开发一种增强阿尔茨海默病三联突触的小分子
- 批准号:
10263179 - 财政年份:2020
- 资助金额:
$ 15.42万 - 项目类别:
Development of small molecule activators of glutamate transporter EAAT2 for treatment of Alzheimer's disease
开发用于治疗阿尔茨海默病的谷氨酸转运蛋白 EAAT2 小分子激活剂
- 批准号:
9752404 - 财政年份:2017
- 资助金额:
$ 15.42万 - 项目类别:
Translational regulation of glutamate transporter EAAT2 & therapeutic application
谷氨酸转运蛋白 EAAT2 的翻译调控
- 批准号:
8114524 - 财政年份:2009
- 资助金额:
$ 15.42万 - 项目类别:
Translational regulation of glutamate transporter EAAT2 & therapeutic application
谷氨酸转运蛋白 EAAT2 的翻译调控
- 批准号:
7736933 - 财政年份:2009
- 资助金额:
$ 15.42万 - 项目类别:
MECHANISMS FOR GLUTAMATE TRANSPORTER ALTERATIONS IN ALZH
ALZH 中谷氨酸转运蛋白改变的机制
- 批准号:
6538930 - 财政年份:1999
- 资助金额:
$ 15.42万 - 项目类别:
ABERRANT TRANSCRIPTS IN AGE RELATED NEURAL DISORDERS
年龄相关神经疾病的异常转录
- 批准号:
6224286 - 财政年份:1999
- 资助金额:
$ 15.42万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 15.42万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 15.42万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 15.42万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 15.42万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 15.42万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 15.42万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 15.42万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 15.42万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 15.42万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 15.42万 - 项目类别: